Mcc Meili Cloud Computing Industry Investment (000815.SZ): Stopping the papermaking business will not trigger the new delisting rules.
Yunnan Weixin (000815.SZ) issued a stock price abnormality announcement, stating that this time it will shut down its papermaking business, liquidate and cancel its wholly-owned subsidiary...
Mcc Meili Cloud Computing Industry Investment (000815.SZ) announced a stock price abnormality notice, stating that the closure of the paper business and the liquidation and cancellation of its wholly-owned subsidiary Ningxia Galaxy New Material Technology Co., Ltd. is expected to have an impact on the company's financial and production operations. The financial statements of the company's consolidated scope will change accordingly. It is expected that there will be a full year loss, but in the long run, it is in line with the company's strategic layout and the interests of all shareholders, and conducive to achieving the company's sustainable, healthy, and stable development. At the same time, by stopping the paper business, based on the revenue and profit situation of the company's data center and new energy business, it will not trigger the delisting regulations.
Related Articles

HEALTHYWAY INC (02587) 2025 Annual Report Decoded: Demand and Capacity Resonance Leading the New Journey of the Medical Industry.

Triumph New Energy (01108) announced its annual performance with a net loss of 914 million yuan, a year-on-year increase of 49.91%.

CHINAGOLDINTL (02099) announces a net profit of approximately $472 million in 2025, a year-on-year increase of 623.32%. It will distribute $0.47 per share.
HEALTHYWAY INC (02587) 2025 Annual Report Decoded: Demand and Capacity Resonance Leading the New Journey of the Medical Industry.

Triumph New Energy (01108) announced its annual performance with a net loss of 914 million yuan, a year-on-year increase of 49.91%.

CHINAGOLDINTL (02099) announces a net profit of approximately $472 million in 2025, a year-on-year increase of 623.32%. It will distribute $0.47 per share.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


